These recent publications bring evidences for EG-VEGF association to key angiogenic processes and support the interest of new investigations on the predictive value of this factor in several pregnancy-associated pathologies including recurrent pregnancy loss, gestational trophoblastic disease, and placental pathologies associated with fetal growth restriction and/or preeclampsia. The gene discussed is VEGFA; the disease is preeclampsia.